Announcements Trials
Browse Landscape

Phase

Phase 4 2

Status

Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Conditions

ACTH Syndrome, Ectopic 4Cushing Syndrome 3Hypertension 2Adrenal Hyperplasia, Congenital 2Adrenal Cortex Neoplasms 1Acth-Independent Macronodular Adrenal Hyperplasia 1

Interventions

relacorilant 5Nutrition Assessment 4Hydrochlorothiazide 4Bevacizumab 3Amlodipine 3aliskiren 2Osilodrostat 2Lisinopril 2Labetalol 2Angiotensin-Converting Enzyme Inhibitors 2Adrenalectomy 2ziprasidone 1sacubitril and valsartan sodium hydrate drug combination 1pembrolizumab 1pazopanib 1lutetium Lu 177 dotatate 1ganirelix 1gallium Ga 68 dotatate 1fimasartan 1enzalutamide 1clevidipine 1cediranib 1bicalutamide 1benazepril 1Zolpidem 1Warfarin 1Vitamin D 1Vecuronium Bromide 1Vancomycin 1Urine Specimen Collection 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Hypertension × Osilodrostat × Clear all
NCT07247058 2026-03-05

Isturisa Treatment in Mild Autonomous Cortisol Secretion( MACS)

Johns Hopkins University

Phase 4 Recruiting
10 enrolled

ACTH Syndrome, Ectopic, Adrenal Hyperplasia, Congenital, Hypertension

NCT07247162 2025-12-10

LINC CARE

RECORDATI GROUP

Phase 4 Not yet recruiting
63 enrolled

ACTH Syndrome, Ectopic, Cushing Syndrome, Hypertension

Data powered by HemOnc (CC BY 4.0) Colophon âš¡